Current Genomics · 2024 · 15 citations · 28 references
FAT4 mutation is relevant to TMB and favorable prognosis in GC, which may become a useful biomarker for immunotherapy of GC patients.
28
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers, Caitlin Connelly, David Fabrizio et al. · Genome Medicine · 2017 · 3.6K citations · Full text
Diana M. Merino, Lisa M. McShane, David Fabrizio et al. · Journal for ImmunoTherapy of Cancer · 2020 · 491 citations · Full text